MADRID, January 2, 2018 /PRNewswire/ -- PharmaMar (MCE:PHM) has announced today a commercialization and distribution license agreement with Megapharm Ltd. for the marine-derived anticancer drug Aplidin® (plitidepsin) in Israel and the territory known as the Palestinian Authority....
from PR Newswire: //www.prnewswire.co.uk/news-releases/pharmamar-signs-a-commercialization-and-distribution-license-agreement-for-aplidin-plitidepsin-with-667694093.html
No comments:
Post a Comment